Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.705 USD | -3.12% | +4.55% | +205.31% |
05-09 | Earnings Flash (NKTR) NEKTAR THERAPEUTICS Reports Q1 Revenue $21.6M, vs. Street Est of $15.3M | MT |
05-09 | Transcript : Nektar Therapeutics, Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+205.31% | 323M | |
+29.61% | 684B | |
+30.34% | 568B | |
-3.88% | 361B | |
+17.63% | 329B | |
+4.22% | 284B | |
+16.21% | 240B | |
+9.66% | 208B | |
-6.83% | 200B | |
+7.38% | 166B |
- Stock Market
- Equities
- NKTR Stock
- News Nektar Therapeutics
- BofA Securities Downgrades Nektar Therapeutics to Underperform from Neutral, Adjusts Price Target to $6 from $18